Sun Pharmaceuticals Launches Drug For Advanced Breast Cancer Patients

Sun Pharmaceutical on Wednesday launched a novel anti-cancer drug Palbociclib under the brand name of Palenotm for patients with advanced breast cancer.

Topics

Sun Pharma | breast cancer | Pharmaceutical companies

Press Trust of India  |  Mumbai 



Fighting breast cancer with AI-powered mobile, non-invasive solutions

Representative image

').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();

Sun Pharmaceutical on Wednesday launched a novel anti-cancer drug Palbociclib under the brand name of Palenotm for patients with advanced .

The company said the generic drug will be available in 75, 100, 125 mgs.

Kirti Ganorkar, chief executive of Sun Pharma's domestic business, said the new drug will be priced at an affordable rate but did not disclose the same. Palenotm will address the treatment needs of several advanced patients.

The company will also introduce a patient assistance programme that will improve patient compliance and accessibility, Ganorkar added.

Palbociclib, which is a generic medicine, is approved by the USFDA, EMA and CDSCO in combination with hormonal therapies for patients with hormone receptor positive, human epidermal growth factor receptor, negative locally advanced or metastatic breast cancers.

affects around 0.21 million women every year. Among the total patients, around 50 per cent are hormone receptor positive, the major subtype in breast cancer.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

First Published: Wed, January 11 2023. 19:05 IST


RECENT NEWS

JPMorgan's Berlin Moment: Chase Takes On Europe

There is something quietly symbolic about JPMorgan Chase choosing Berlin as its gateway into continental Europe. In a fo... Read more

What Strategy's Bitcoin Sale Really Tells Us

There is a moment in every bull run when the narrative starts to fray. Not with a crash, not with a scandal, but with so... Read more

Coutts Sets Scope On New Continent

Coutts steps into private marketsCoutts, the private bank best known for serving Britain’s wealthiest families and the... Read more

From Cypherpunk To Citadel

How Crypto Moved from the Wild West to the Mainstream Financial SystemA long-form analysis of Bitcoin's journey from fri... Read more

ACB Securities: Building Scale, Trust & Innovation

ACB Securities: Building Scale, Trust and Innovation in Vietnam’s Capital MarketsACB Securities (ACBS) is emerging as ... Read more

War Risk Returns To Markets As VIX Surges

For most of the past year, global markets behaved as though geopolitical risk had largely disappeared. Inflation was eas... Read more